Literature DB >> 15167063

Migraine aura: new information on underlying mechanisms.

Margarita Sánchez-del-Rio1, Uwe Reuter.   

Abstract

PURPOSE OF REVIEW: Since the initial description of cortical spreading depression by Leao, evidence that cortical spreading depression is the underlying pathomechanism of migraine aura has increased. The purpose of this review is to describe the ultimate genetic and molecular mechanisms of migraine aura. RECENT
FINDINGS: It has been debated how a primarily cortical phenomenon (aura phase) may activate trigeminal fibres (headache phase). Recent data have demonstrated a link between cortical events and activation of the pain-sensitive structures of the dura mater. The initial cortical hyperperfusion in cortical spreading depression is partly mediated by the release of trigeminal and parasympathetic neurotransmitters from perivascular nerve fibres, whereas delayed meningeal blood flow increase is mediated by a trigeminal-parasympathetic brainstem connection. With regard to molecular mechanisms, cortical spreading depression upregulates a variety of genes coding for COX-2, TNF-alpha and IL-1beta, galanin or metalloproteinases. The activation of metalloproteinases leads to leakage of the blood-brain barrier, allowing potassium, nitric oxide, adenosine and other products released by cortical spreading depression to reach and sensitize the dural perivascular trigeminal afferents. In familial hemiplegic migraine, new mutations have been described in chromosome 1q23, leading to a haploinsufficiency of the sodium/potassium pump, producing an increase in intracellular calcium, similar to the CACNA1A mutation.
SUMMARY: Recent studies have helped unravel the basic mechanisms involved in migraine aura. Far from being a simple phenomenon, a sequence of events leads from the cortex to the activation of pain-sensitive structures. The role of the brainstem is still poorly described. The identification of target molecules may provide new therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167063     DOI: 10.1097/00019052-200406000-00009

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  14 in total

Review 1.  Neuron-glial interactions in blood-brain barrier formation.

Authors:  Swati Banerjee; Manzoor A Bhat
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

2.  Transient global amnesia in a patient with high and persistent levels of antiphospholipid antibodies.

Authors:  Norberto Ortego-Centeno; José Luis Callejas-Rubio; Miguel Guerrero Fernández; Miguel Gómez Camello
Journal:  Clin Rheumatol       Date:  2005-10-06       Impact factor: 2.980

Review 3.  Visual disturbances and migraine.

Authors:  Charles E Maxner; Jeremy J Moeller
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

Review 4.  Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.

Authors:  Esmée Vendel; Elizabeth C M de Lange
Journal:  Neuromolecular Med       Date:  2014-06-15       Impact factor: 3.843

5.  The minicolumnopathy of autism: A link between migraine and gastrointestinal symptoms.

Authors:  Manuel F Casanova
Journal:  Med Hypotheses       Date:  2007-06-14       Impact factor: 1.538

Review 6.  [What is migraine?].

Authors:  M Schürks
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

Review 7.  [Pathophysiology of migraine and clinical implications].

Authors:  M Schürks; H-C Diener
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

8.  Differential activation of extracellular signal-regulated kinase 1 and a related complex in neuronal nuclei.

Authors:  Joseph J Lundquist; Serena M Dudek
Journal:  Brain Cell Biol       Date:  2008-04-05

Review 9.  Development, maintenance and disruption of the blood-brain barrier.

Authors:  Birgit Obermeier; Richard Daneman; Richard M Ransohoff
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

Review 10.  Genetics of migraine in the age of genome-wide association studies.

Authors:  Markus Schürks
Journal:  J Headache Pain       Date:  2011-11-11       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.